tiprankstipranks
Trending News
More News >
Yuki Gosei Kogyo Co., Ltd. (JP:4531)
:4531
Japanese Market
Advertisement

Yuki Gosei Kogyo Co., Ltd. (4531) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4531

Yuki Gosei Kogyo Co., Ltd.

(4531)

Rating:73Outperform
Price Target:
¥293.00
▲(10.98%Upside)
The company's financial performance is strong, with consistent revenue growth and solid profitability margins. Valuation metrics suggest the stock is undervalued with an attractive dividend yield. Technical indicators show mixed signals, with the stock slightly above its short-term moving average but other indicators suggesting caution. The lack of earnings call data and notable corporate events limits additional insights.

Yuki Gosei Kogyo Co., Ltd. (4531) vs. iShares MSCI Japan ETF (EWJ)

Yuki Gosei Kogyo Co., Ltd. Business Overview & Revenue Model

Company DescriptionYuki Gosei Kogyo Co., Ltd. is a Japanese chemical company specializing in the production and sale of fine chemicals and pharmaceuticals. The company operates primarily in the chemical sector, offering a diverse range of products including intermediates for pharmaceuticals, agrochemicals, and specialty chemicals. Yuki Gosei Kogyo is known for its innovative approach to chemical synthesis and its commitment to high-quality production standards.
How the Company Makes MoneyYuki Gosei Kogyo Co., Ltd. generates revenue through the manufacturing and sale of its chemical products. Its key revenue streams include the sale of pharmaceutical intermediates, which are critical components in the production of various drugs, and specialty chemicals used in industries such as agriculture and manufacturing. The company may also engage in partnerships and collaborations with other firms to enhance its product offerings and market reach. Additionally, Yuki Gosei Kogyo's focus on research and development enables it to create innovative products that meet the evolving needs of its clients, thereby sustaining its revenue growth.

Yuki Gosei Kogyo Co., Ltd. Financial Statement Overview

Summary
Yuki Gosei Kogyo Co., Ltd. shows solid financial health with steady revenue growth and improved profitability margins. The balance sheet remains robust with a stable equity base and manageable debt levels. However, the company faces challenges with negative free cash flow due to high capital expenditures, which need to be managed carefully.
Income Statement
80
Positive
The company has demonstrated consistent revenue growth over the past five years, with a revenue increase from ¥10,717 million in 2020 to ¥15,128 million in 2025. Gross profit margins have been stable, averaging around 20% over recent years, indicating efficient production and pricing strategies. Net profit margins have improved, particularly in the last two years, showing enhanced profitability and cost control. EBITDA margins have also strengthened, reflecting robust operating performance.
Balance Sheet
75
Positive
The balance sheet is strong with an improving equity position, as stockholders' equity has grown from ¥10,535 million in 2020 to ¥13,106 million in 2025. The debt-to-equity ratio has been stable, indicating manageable leverage levels. Return on equity has shown positive trends, suggesting efficient use of equity capital. However, the increasing total debt to ¥8,418 million warrants monitoring for potential leverage risks.
Cash Flow
70
Positive
Operating cash flow has been positive and growing, supporting the company's operational needs. However, free cash flow has been negative in recent years due to significant capital expenditures, which might indicate strategic investments or expansion. The operating cash flow to net income ratio is strong, showcasing good cash conversion efficiency, although consistent negative free cash flow could pose a challenge if not managed well.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue15.13B12.93B12.84B12.36B11.09B
Gross Profit3.23B3.26B3.05B2.36B1.82B
EBITDA2.23B1.88B1.56B1.18B1.27B
Net Income896.00M776.00M556.00M248.00M288.00M
Balance Sheet
Total Assets26.87B24.37B22.12B21.17B21.00B
Cash, Cash Equivalents and Short-Term Investments973.00M588.00M1.14B1.86B1.26B
Total Debt8.42B6.78B5.58B5.50B6.10B
Total Liabilities13.76B11.94B10.64B10.17B10.05B
Stockholders Equity13.11B12.43B11.48B11.00B10.95B
Cash Flow
Free Cash Flow-1.20B-1.37B-490.00M1.40B-208.00M
Operating Cash Flow2.14B388.00M668.00M1.79B352.00M
Investing Cash Flow-3.25B-1.89B-1.24B-442.00M-648.00M
Financing Cash Flow1.50B948.00M-158.00M-772.00M106.00M

Yuki Gosei Kogyo Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price264.00
Price Trends
50DMA
262.42
Positive
100DMA
257.80
Positive
200DMA
257.38
Positive
Market Momentum
MACD
0.33
Negative
RSI
55.52
Neutral
STOCH
83.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4531, the sentiment is Positive. The current price of 264 is above the 20-day moving average (MA) of 263.25, above the 50-day MA of 262.42, and above the 200-day MA of 257.38, indicating a bullish trend. The MACD of 0.33 indicates Negative momentum. The RSI at 55.52 is Neutral, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4531.

Yuki Gosei Kogyo Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥8.37B9.76
2.05%13.02%
76
Outperform
¥7.50B6.37
1.71%4.57%-13.43%
73
Outperform
¥5.78B6.41
3.40%16.98%16.45%
71
Outperform
¥2.72B12.21
3.39%10.31%77.52%
59
Neutral
¥4.59B34.96
1.25%5.14%1.96%
57
Neutral
£2.65B4.95-9.48%6884.14%5.31%-6.23%
46
Neutral
¥4.43B521.41
2.92%-3.17%-21.99%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4531
Yuki Gosei Kogyo Co., Ltd.
264.00
-33.02
-11.12%
JP:4040
NANKAI CHEMICAL COMPANY LIMITED
3,220.00
95.19
3.05%
JP:4360
MANAC Chemical Partners Co.,Ltd
514.00
-74.32
-12.63%
JP:4366
Daito Chemix Corporation
786.00
93.81
13.55%
JP:4885
MUROMACHI CHEMICALS INC.
743.00
-43.77
-5.56%
JP:4960
Chemipro Kasei Kaisya,Ltd.
281.00
-122.84
-30.42%

Yuki Gosei Kogyo Co., Ltd. Corporate Events

Yuki Gosei Kogyo Co., Ltd. Reports Strong Financial Growth
Jan 31, 2025

Yuki Gosei Kogyo Co., Ltd. reported strong financial performance for the nine months ending December 31, 2024, with net sales increasing by 21.4% compared to the same period the previous year. This growth was accompanied by substantial increases in operating income, ordinary income, and net income, reflecting improved operational efficiency and market positioning. The company has not revised its financial forecast for the fiscal year ending March 31, 2025, indicating confidence in its projected growth, which is expected to see a continued increase in net sales and income.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 24, 2025